A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models ; volume:23 ; number:1 ; day:2 ; month:6 ; year:2023 ; pages:1-9 ; date:12.2023
BMC cancer ; 23, Heft 1 (2.6.2023), 1-9, 12.2023
- Urheber
-
Mrdenovic, Stefan
Wang, Yanping
Yin, Lijuan
Chu, Gina Chia-Yi
Ou, Yan
Lewis, Michael S.
Heffer, Marija
Posadas, Edwin M.
Zhau, Haiyen E.
Chung, Leland W. K.
Edderkaoui, Mouad
Pandol, Stephen J.
Wang, Ruoxiang
Zhang, Yi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-10878-3
- URN
-
urn:nbn:de:101:1-2023091313041334016200
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mrdenovic, Stefan
- Wang, Yanping
- Yin, Lijuan
- Chu, Gina Chia-Yi
- Ou, Yan
- Lewis, Michael S.
- Heffer, Marija
- Posadas, Edwin M.
- Zhau, Haiyen E.
- Chung, Leland W. K.
- Edderkaoui, Mouad
- Pandol, Stephen J.
- Wang, Ruoxiang
- Zhang, Yi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer
A Tick Cysteine Protease Inhibitor RHcyst-1 Exhibits Antitumor Potential
Natural killer cells strengthen antitumor activity of cisplatin by immunomodulation and ameliorate cisplatin-induced side effects
TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
A variant of guanidine-IV riboswitches exhibits evidence of a distinct ligand specificity
Betulinaldehyde exhibits effective anti-tumor effects in A549 cells by regulating intracellular autophagy
Exhibits
Exhibits
Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancer
Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer
A Tick Cysteine Protease Inhibitor RHcyst-1 Exhibits Antitumor Potential
Natural killer cells strengthen antitumor activity of cisplatin by immunomodulation and ameliorate cisplatin-induced side effects
TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
A variant of guanidine-IV riboswitches exhibits evidence of a distinct ligand specificity
Betulinaldehyde exhibits effective anti-tumor effects in A549 cells by regulating intracellular autophagy
Exhibits
Exhibits
Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancer
Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer
A Tick Cysteine Protease Inhibitor RHcyst-1 Exhibits Antitumor Potential
Natural killer cells strengthen antitumor activity of cisplatin by immunomodulation and ameliorate cisplatin-induced side effects
TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
A variant of guanidine-IV riboswitches exhibits evidence of a distinct ligand specificity
Betulinaldehyde exhibits effective anti-tumor effects in A549 cells by regulating intracellular autophagy
Exhibits
Exhibits
Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab